Latest News

Lilly’s Oral GLP-1 Orforglipron Shows Significant A1c and Weight Reductions in Phase 3 Trial / image credit ©MichaelVi/stock.adobe.com
Lilly’s Oral GLP-1 Orforglipron Shows Significant and Competitive A1c and Weight Reductions in Phase 3 Trial

April 17th 2025

The positive topline data from the phase 3 ACHIEVE-1 trial suggest the small molecule GLP-1 mimetic could compete with blockbuster weekly injectables for reducing weight, A1c.

 Mediterranean Diet Combined with Physical Activity Mitigate Bone Density Decline in Older, At-Risk Women, New Analysis Finds / image credit  Rovira i Virgili University
Mediterranean Diet Combined with Physical Activity Mitigate Bone Density Decline in Older, At-Risk Women, New Analysis Finds

April 15th 2025

Novel Non-Invasive Glucose Monitor Uses Light-Based Technology / image credit RSP Systems
Novel Non-Invasive Glucose Monitor Uses Light-Based Technology

April 11th 2025

Dexcom G7 15 Day CGM System Cleared by FDA  / image credit ©Waldenmarus/stock.adobe.com
Dexcom G7 15 Day CGM System Cleared by FDA

April 10th 2025

Incretin-Based Obesity Medications Show Minimal Lean Muscle Mass Loss in 6-Month Prospective Study / image courtesy of Weight Wellness Medicine
Incretin-Based Obesity Medications Show Minimal Lean Muscle Mass Loss in 6-Month Prospective Study

April 10th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.